[Federal Register Volume 72, Number 38 (Tuesday, February 27, 2007)]
[Notices]
[Page 8793]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-3297]



[[Page 8793]]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Application

    Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to 
issuing a registration under this Section to a bulk manufacturer of a 
controlled substance in schedule I or II and prior to issuing a 
regulation under 21 U.S.C. 952(a) authorizing the importation of such a 
substance, provide manufacturers holding registrations for the bulk 
manufacture of the substance an opportunity for a hearing.
    Therefore, in accordance with 21 CFR 1301.34(a), this is notice 
that on January 9, 2007, Sigma Aldrich Manufacturing LLC., Subsidiary 
of Sigma-Aldrich Company, 3500 Dekalb Street, St. Louis, Missouri 
63118, made application by renewal to the Drug Enforcement 
Administration (DEA) to be registered as an importer of the basic 
classes of controlled substances listed in schedule I and II:

------------------------------------------------------------------------
                             Drug                               Schedule
------------------------------------------------------------------------
Cathinone (1235).............................................          I
Methcathinone (1237).........................................          I
Aminorex (1585)..............................................          I
Gamma Hydroxybutyric Acid (2010).............................          I
Methaqualone (2565)..........................................          I
Ibogaine (7260)..............................................          I
Lysergic acid diethylamide (7315)............................          I
Marihuana (7360).............................................          I
Tetrahydrocannabinols (7370).................................          I
Mescaline (7381).............................................          I
4-Bromo-2,5-dimethoxyamphetamine (7391)......................          I
4-Bromo-2,5-dimethoxyphenethylamine (7392)...................          I
4-Methyl-2,5-dimethoxyamphetamine (7395).....................          I
2,5-Dimethoxyamphetamine (7396)..............................          I
3,4-Methylenedioxyamphetamine (7400).........................          I
N-Hydroxy-3,4-methylenedioxyamphetamine (7402)...............          I
3,4-Methylenedioxy-N-ethylamphetamine (7404).................          I
3,4-Methylenedioxymethamphetamine (MDMA) (7405)..............          I
4-Methoxyamphetamine (7411)..................................          I
Bufotenine (7433)............................................          I
Diethyltryptamine (7434).....................................          I
Dimethyltryptamine (7435)....................................          I
Psilocybin (7437)............................................          I
Psilocyn (7438)..............................................          I
N-Ethyl-1-phenylcyclohexylamine (7455).......................          I
N-Benzylpiperazine (BZP) (7493)..............................          I
Trifluoromethylphenyl Piperazine (7494)......................          I
Heroin (9200)................................................          I
Normorphine (9313)...........................................          I
Etonitazene (9624)...........................................          I
Amphetamine (1100)...........................................         II
Methamphetamine (1105).......................................         II
Methylphenidate (1724).......................................         II
Amobarbital (2125)...........................................         II
Pentobarbital (2270).........................................         II
Secobarbital (2315)..........................................         II
Glutethimide (2550)..........................................         II
Nabilone (7379)..............................................         II
Phencyclidine (7471).........................................         II
Cocaine (9041)...............................................         II
Codeine (9050)...............................................         II
Diprenorphine (9058).........................................         II
Oxycodone (9143).............................................         II
Hydromorphone (9150).........................................         II
Diphenoxylate (9170).........................................         II
Ecgonine (9180)..............................................         II
Ethylmorphine (9190).........................................         II
Hydrocodone (9193)...........................................         II
Levorphanol (9220)...........................................         II
Meperidine (9230)............................................         II
Methadone (9250).............................................         II
Dextropropoxyphene, bulk (non-dosage forms) (9273)...........         II
Morphine (9300)..............................................         II
Thebaine (9333)..............................................         II
Opium powdered (9639)........................................         II
Oxymorphone (9652)...........................................         II
Fentanyl (9801)..............................................         II
------------------------------------------------------------------------

    The company plans to import the listed controlled substances for 
sale to research facilities for drug testing and analysis.
    Any bulk manufacturer who is presently, or is applying to be, 
registered with DEA to manufacture such basic classes of controlled 
substances may file comments or objections to the issuance of the 
proposed registration and may, at the same time, file a written request 
for a hearing on such application pursuant to 21 CFR 1301.43 and in 
such form as prescribed by 21 CFR 1316.47.
    Any such written comments or objections being sent via regular mail 
should be addressed, in quintuplicate, to the Deputy Assistant 
Administrator, Office of Diversion Control, Drug Enforcement 
Administration, Washington, D.C. 20537, Attention: DEA Federal Register 
Representative/ODL; or any being sent via express mail should be sent 
to DEA Headquarters, Attention: DEA Federal Register Representative/
ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must 
be filed no later than March 29, 2007.
    This procedure is to be conducted simultaneously with and 
independent of the procedures described in 21 CFR 1301.34(b), (c), (d), 
(e) and (f). As noted in a previous notice published in the Federal 
Register on September 23, 1975, (40 FR 43745-46), all applicants for 
registration to import a basic classes of any controlled substances 
listed in schedule I or II are, and will continue to be required to 
demonstrate to the Deputy Assistant Administrator, Office of Diversion 
Control, Drug Enforcement Administration, that the requirements for 
such registration pursuant to 21 U.S.C. 958(a), 21 U.S.C. 823(a), and 
21 CFR 1301.34(b), (c), (d), (e) and (f) are satisfied.

    Dated: February 16, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E7-3297 Filed 2-26-07; 8:45 am]
BILLING CODE 4410-09-P